The takeover deal – worth up to $1.15 billion including $550 million in upfront cash – will upgrade the Dutch biotech's ...

More than ever, pharma firms are under increasing pressure to harness the power of AI, advanced analytics, and machine ...

Amazon Web Services (AWS) has committed $100 million in AI and cloud technology capacity to support the building of health ...

The comprehensive failure of Lp (a)HORIZON has cast a pall over the prospects for other Lp (a)-targeting drugs, including ...

Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies Zepbound and Foundayo sold ...

Theramex, a London, UK-based specialty pharma company focusing on women's health, is changing hands in a deal reportedly ...

Patients with muscle-invasive bladder cancer can now receive NHS treatment with a regimen of MSD's Keytruda and Astellas' ...

The US federal government has awarded $99 million in funding for a one-shot vaccine against the Bundibugyo virus (BDBV), the ...

Boehringer Ingelheim is paying $358 million upfront to claim options on up to six antibody-drug conjugates (ADCs) and T cell ...

Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy, which ...

Moderna's mRNA-1469 and ChAdOx1, developed by the University of Oxford in partnership with the Serum Institute of India, ...

Belén Garijo, who took over the reins of the French pharma group in April, said this morning that Sanofi's "whole ...